WuXi TIDES Brochure: CRDMO platform for Oligonucleotide, Peptide and Complex Conjugate
WuXi TIDES Oligonucleotide, Peptide & Complex Conjugates Business Introduction
Free Registration: Oligonucleotide Facility Virtual Tour
We'd like to invite you to join a virtual tour of our oligonucleotide facilities at WuXi TIDES. Please contact us for the full tour.
Case Study: Accelerate Commercial Manufacturing of an Oligonucleotide Adjuvant with WuXi Speed_Introduction_
In 2021, a biotech company was developing a vaccine that needed large scale oligonucleotide production capacity and rapid turnaround to produce hundreds of kilo oligonucleotide adjuvant.
Oligonucleotide CRDMO Chemistry Platform
Here's the brief overview of oligonucleotide molecules we support.
Case Study: IND Ready in 11 Months for a PPMO Drug Candidate
WuXi STA has built an integrated new modality CRDMO platform with our experienced oligonucleotide and peptide teams. This video demonstrated an example of our integrated platform accelerating our client's PPMO project in 11 months.